Serum uric acid level is associated with the prevalence but not with survival of amyotrophic lateral sclerosis in a Chinese population

被引:0
作者
Zhenzhen Zheng
Xiaoyan Guo
Qianqian Wei
Wei Song
Bei Cao
Rui Huang
Ruwei Ou
Xueping Chen
Huifang Shang
机构
[1] SiChuan University,Department of Neurology, West China Hospital
来源
Metabolic Brain Disease | 2014年 / 29卷
关键词
Amyotrophic lateral sclerosis; Motor neuron diseases; Uric acid; Prevalence; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
Oxidative stress is involved in the pathogenesis of amyotrophic lateral sclerosis (ALS). Serum uric acid (UA) has anti-oxidative effect. To clarify the associations between UA and sporadic ALS (SALS) in Chinese population. A total of 512 SALS patients and 501 age- and gender- matched healthy controls were included, with fasting serum UA evaluated. The ALS functional rating scale-Revised was used to assess disease severity, and the mean change of ALSFRS-R per month (△ALS-FRS-R/m) to assess its progression. Four hundred forty-five patients were followed up. Survival and progression were estimated according to quartiles and gender-specific quartiles of UA. The mean age of SALS patients was 53.3 ± 11.7 years. UA level of SALS was significantly lower than controls (p = 0.001). Male SALS had higher UA than female (p = 0.001). The occurrence of SALS was increased in the lowest, second and third quartiles compared with the highest quartile (p = 0.001). In the gender-specific analysis, increased occurrence was found in the lowest and second quartiles compared with third and fourth quartiles in both males and females SALS (pf = 0.001 and pm < 0.05). No correlation was found between △ALS-FRS-R/m and UA (p > 0.05), nor between SALS survival and UA. SALS patients have low level of serum UA than controls. Low level of uric acid may be associated with increased occurrence of SALS in Chinese population. Uric acid level may not contribute to the survival or progression of SALS.
引用
收藏
页码:771 / 775
页数:4
相关论文
共 122 条
  • [1] Amaro S(2008)Uric acid administration in patients with acute stroke: a novel approach to neuroprotection Expert Rev Neurother 8 259-70
  • [2] Planas AM(1981)Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis Proc Natl Acad Sci U S A 78 6858-62
  • [3] Chamorro A(2009)Urate as a predictor of the rate of clinical decline in Parkinson disease Arch Neurol 66 1460-8
  • [4] Ames BN(2010)The relationship between uric acid levels and Huntington’s disease progression Mov Disord 25 224-8
  • [5] Cathcart R(2006)Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target Biochim Biophys Acta 1762 1051-67
  • [6] Schwiers E(1995)Oxidative stress: its role in the pathogenesis of amyotrophic lateral sclerosis J Neurol Sci 129 Suppl 81-4
  • [7] Hochstein P(2006)Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study Stroke 37 1503-7
  • [8] Ascherio A(1994)El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors J Neurol Sci 124 Suppl 96-107
  • [9] LeWitt PA(2007)Neuroprotective agents for clinical trials in ALS: systematic assessment Neurology 68 709-8
  • [10] Xu K(1974)Dissociation between results of in vitro and in vivo antibiotic susceptibility tests for some strains of Pseudomonas aeruginosa Antimicrob Agents Chemother 5 281-800